Genki Okumura
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Clinical, immunological, and genomic findings of atezolizumab in advanced alveolar soft part sarcoma: A phase II trial (ALBERT trial/NCCH1907).
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 31, 2025
Spatial Multiomic Analyses Reveal Carcinogenic Pathways in End-Stage Renal Disease.
Journal: Cancer discovery
Published: March 25, 2025
Essential role of CD155 glycosylation in functional binding to DNAM-1 on natural killer cells.
Journal: International immunology
Published: August 22, 2023
Hemagglutinating virus of Japan-envelope containing programmed cell death-ligand 1 siRNA inhibits immunosuppressive activities and elicits antitumor immune responses in glioma.
Journal: Cancer science
Published: July 19, 2020
Tumor-derived soluble CD155 inhibits DNAM-1-mediated antitumor activity of natural killer cells.
Journal: The Journal of experimental medicine
Published: July 13, 2019
High expression of soluble CD155 in estrogen receptor-negative breast cancer.
Journal: Breast cancer (Tokyo, Japan)
Published: March 12, 2019
Development and Characterization of Novel Monoclonal Antibodies Against Human DNAM-1.
Journal: Monoclonal antibodies in immunodiagnosis and immunotherapy
Published: May 13, 2017
Last Updated: 09/26/2026